Healthcare entity
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Butterfly Network, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 5.7 in the same window.
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Butterfly Network, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. Each story carries 4 original sources on average, compared with 4 for the broader beat in this window. We currently track 1 Healthcare story that mention Delcath Systems, all published on February 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Delcath Systems. Shared-story counts are live from our verified record — not editorial picks.
Delcath Systems, Lantheus Holdings, Butterfly Network, and Heron Therapeutics are preparing to report Q4 2025 earnings, marking a critical test for commercial-stage medical innovators. Investors are laser-focused on the adoption rates of flagship products like HEPZATO KIT and PYLARIFY as these companies navigate a complex reimbursement environment.
Source: Seeking Alpha · Seeking Alpha
Delcath Systems is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
